2002
DOI: 10.1002/1521-4141(200203)32:3<752::aid-immu752>3.0.co;2-5
|View full text |Cite
|
Sign up to set email alerts
|

Generation of adult-like antibody avidity profiles after early-life immunization with protein vaccines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
18
1
1

Year Published

2003
2003
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 37 publications
(21 citation statements)
references
References 44 publications
1
18
1
1
Order By: Relevance
“…This would primarily affect the functional capacity, not just the level of Abs. The MV-specific ASC found in the BM might correspond to low avidity clones, already described in mice immunized as neonates with other vaccine Ags (49).…”
Section: Discussionsupporting
confidence: 63%
“…This would primarily affect the functional capacity, not just the level of Abs. The MV-specific ASC found in the BM might correspond to low avidity clones, already described in mice immunized as neonates with other vaccine Ags (49).…”
Section: Discussionsupporting
confidence: 63%
“…Similarly, increased Ag dose and time of Ag availability have been shown to substitute for FDC-stored Ab-complexed Ags in the induction of IgG responses in TNFR1 Ϫ/Ϫ mice devoid of classical GC (55). It is also of interest to note that although the delayed and limited early life GC reaction significantly limits ASC differentiation and primary IgG responses, it is nevertheless sufficient to allow the generation of memory B cells (20) and the Ab avidity maturation of certain T-dependent protein Ags (56). This is in accordance with the fact that memory B cells are generated relatively late in the GC reaction (57) while the avidity maturation process may extend beyond the GC compartment.…”
Section: Discussionmentioning
confidence: 63%
“…3D). An increase of overall avidity through the use of aluminum salts as adjuvants has previously been described in immunization studies in mice and humans (54,55,65). Second, through the use of a mutant DIII with modifications at the so-called lateral ridge epitope originally described in the West Nile virus system (36), we found that the ϪAlu group had a higher proportion of antibodies against this specific epitope than the ϩAlu group.…”
Section: Discussionmentioning
confidence: 99%